Comparison Log
2023-05-14 04:12:42.347414
mwtab Python Library Version: 1.2.5
Source:      https://www.metabolomicsworkbench.org/rest/study/analysis_id/AN003105/mwtab/...
Study ID:    ST001908
Analysis ID: AN003105
Status:      Inconsistent

Sections "SUBJECT" contain missmatched items: {('HUMAN_INCLUSION_CRITERIA', 'a. Clinically diagnosed ST-elevation myocardial infarction (STEMI) • Typical history of ischemic chest pain or angina equivalent symptoms (acute onset dyspnea) • ECG changes of at least 2 contiguous leads of ≥2 mm (0.2 mV) in men or ≥1.5 mm (0.15 mV) in women in leads V2–V3 and/or of ≥1 mm (0.1 mV) in other contiguous chest leads or the limb leads • Presence of Q waves • Typical rise and fall of cardiac enzymes (cTn value exceeding the 99th percentile URL (in ng/L or pg/mL) OR Clinically diagnosed nonST-elevation myocardial infarction (NSTEMI) • ECG changes of ST-segment depression or prominent T-wave inversion and/or • positive biomarkers of necrosis (troponin, CKMB) b. Angiographic findings of &gt;50% occlusion of one or more coronary arteries c. Age&gt;21 years and &lt;85 years, d. Ability to provide written informed consent and comply with study protocol requirements.'), ('HUMAN_INCLUSION_CRITERIA', 'a. Clinically diagnosed ST-elevation myocardial infarction (STEMI) • Typical history of ischemic chest pain or angina equivalent symptoms (acute onset dyspnea) • ECG changes of at least 2 contiguous leads of ≥2 mm (0.2 mV) in men or ≥1.5 mm (0.15 mV) in women in leads V2–V3 and/or of ≥1 mm (0.1 mV) in other contiguous chest leads or the limb leads • Presence of Q waves • Typical rise and fall of cardiac enzymes (cTn value exceeding the 99th percentile URL (in ng/L or pg/mL) OR Clinically diagnosed nonST-elevation myocardial infarction (NSTEMI) • ECG changes of ST-segment depression or prominent T-wave inversion and/or • positive biomarkers of necrosis (troponin, CKMB) b. Angiographic findings of  greater than 50% occlusion of one or more coronary arteries c. Age greater than 21 years and  less than 85 years, d. Ability to provide written informed consent and comply with study protocol requirements.'), ('HUMAN_EXCLUSION_CRITERIA', 'a. Patients not able or willing to consent for study b. Severe renal impairment (eGFR less than 15 ml/min/m2) c. Severe liver impairment d. Anaemia  less than 8 g/dl (men) and 7 g/dl (women) e. Cardiogenic shock unable to be weaned off inotropes or IABP f. History of significant valvular heart disease (moderate or severe MS, MR, AS, AR, TR) g. History of malignancy diagnosed within the last 12 months h. Patients who cannot be followed up (non-residents)'), ('HUMAN_EXCLUSION_CRITERIA', 'a. Patients not able or willing to consent for study b. Severe renal impairment (eGFR&lt;15 ml/min/m2) c. Severe liver impairment d. Anaemia &lt; 8 g/dl (men) and 7 g/dl (women) e. Cardiogenic shock unable to be weaned off inotropes or IABP f. History of significant valvular heart disease (moderate or severe MS, MR, AS, AR, TR) g. History of malignancy diagnosed within the last 12 months h. Patients who cannot be followed up (non-residents)')}
'Metabolite'
'Data' section of 'MS_METABOLITE_DATA' block do not match.